SEKISUI DIAGNOSTICS (UK) LIMITED
Get an alert when SEKISUI DIAGNOSTICS (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-12-04 (in 7mo)
Last made up 2025-11-20
Watchouts
None on the register
Accounts
Audit & accounting basis
- Accounting basis
- FRS 101 Reduced Disclosure Framework
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Under both the base case and the severe but plausible downside scenario, the forecasts indicate that the company will have sufficient liquidity to continue to settle its liabilities as they fall due for a period of at least 12 months from the date of approval of the financial statements. Consequently, the Directors believe it is appropriate to continue to prepare the financial statements on a going concern basis.”
Group structure
- SEKISUI DIAGNOSTICS (UK) LIMITED · parent
- Sekisui Diagnostics GmbH 100%
Significant events
- “The loss for the year after taxation amounted to £4,585,776 (year ended 31 March 2024 loss of £4,070,916). The results reflect a combination of reduction in requirements of some Diagnostics Enzyme products and demand growth from some Diagnostic Enzyme customers which is impacting mix and profitability of the Enzyme business, which is being addressed through pricing and cost control measures.”
- “We are part way through a budgeted significant investment (£20M) to enable us to grow our Biopharma CDMO (Contract Development and Manufacturing Organisation) business. R&D and QC labs have been completed and are occupied and the main part of the investment (£18.5M) in a Bio Pharma production facility is partially completed and expected to be commissioned, validated and operational in FY26.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DIGBY, Louise Clare, Mrs. | Director | 2023-12-31 | Oct 1974 | British |
| NAGURA, Masaki | Director | 2025-10-31 | Aug 1965 | Japanese |
| SCHRUENDER, Robert Timothy | Director | 2015-03-01 | Dec 1966 | American |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FUKUDA, Mutsumi | Director | 2011-01-14 | 2014-03-31 |
| KON, Tetsuaki | Director | 2014-03-31 | 2015-03-01 |
| MANABE, Mitsuhisa | Director | 2011-01-14 | 2014-03-31 |
| NEGAMA, Tsutomu | Director | 2020-09-30 | 2025-10-31 |
| STOCKBURN, William Albert, Dr | Director | 2018-06-12 | 2023-12-31 |
| TAGASHIRA, Hideo | Director | 2014-03-31 | 2015-03-01 |
| TAKAHASHI, Eiichi | Director | 2014-10-01 | 2020-09-30 |
| TSUCHIHASHI, Goichi | Director | 2015-03-01 | 2018-06-12 |
| YOSHIDA, Katsuhiro | Director | 2010-12-01 | 2011-02-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Sekisui Chemical Co., Ltd. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 61 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-04 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-04 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-17 | AA | accounts | Accounts with accounts type full | |
| 2025-07-31 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-07-31 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2024-11-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-11-14 | AA | accounts | Accounts with accounts type full | |
| 2024-01-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-10 | TM01 | officers | Termination director company with name termination date | |
| 2023-12-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-13 | AA | accounts | Accounts with accounts type full | |
| 2022-12-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-24 | AA | accounts | Accounts with accounts type full | |
| 2021-12-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-11-29 | AA | accounts | Accounts with accounts type full | |
| 2021-03-23 | AA | accounts | Accounts with accounts type full | |
| 2020-12-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-10-01 | AP01 | officers | Appoint person director company with name date | |
| 2020-09-30 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one